知镜 Cognispect · 医学文献与研究工作台

Ursolic acid-loaded bioactive nanoagents alleviate DNCB-induced atopic dermatitis symptoms by facilitating autophagy and antioxidant defenses.

Liu Z, Wu X, Mei Y, Wang Z, Xu X, Liu J, Liu F, Lou T, Diao A, Lu F, Zhao D, Zhao H.
Biomaterials advances · 2026-09-25 · PMID 42815076

文献摘要

Impaired skin barrier function is a major hallmark of atopic dermatitis (AD). This barrier disruption is driven by the combined effects of autophagy deficiency and excessive reactive oxygen species (ROS) accumulation. Herein, we developed a bifunctional nanoagent (PU) engineered by encapsulating the autophagy-inducing natural compound ursolic acid within the antioxidative hollow mesoporous Prussian blue nanoparticles, and further revealed its multi-network regulatory mechanisms in AD treatment. Mechanistically, PU facilitated the nuclear translocation of ‌transcription factor EB (TFEB) by regulating the AMPK-mTORC1-TFEB signaling axis, promoting the autophagic flux in HaCaT keratinocytes. Furthermore, PU with ROS scavenging activity enhanced endogenous antioxidant defense by activating the Keap1-Nrf2-HO-1 pathway in HaCaT keratinocytes. In DNCB-induced AD mouse model, subcutaneous injection of PU not only promoted tight junction proteins expression, but also repaired the skin barrier function. Ultimately, PU alleviated AD-like symptoms, including inflammatory infiltration and scratching behavior in AD mouse models. This work highlights the potential of bioactive nanoagents loaded with natural compounds to coordinate autophagy activation and antioxidant defense, representing a comprehensive approach for AD treatment.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。